ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentSchlierenMabylon AG
Mabylon AG Logo
Verified· 4 sources

Mabylon AG

Summary

About the company

The core activity of Mabylon AG is research and development in the field of biotechnology.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Antibody-based drug discovery
Discovery and engineering of novel antibody therapeutics using human B-cell screening technologies, high-throughput expression, and antibody engineering for validated targets.
Therapeutics for allergies
Antibody-based therapeutics for food and pollen allergies, in particular for peanut allergy, birch pollen allergy, and grass pollen allergy.
Therapeutics for inflammation and neurodegeneration
Development of human antibodies for inflammatory and neurological diseases, including ALS, Alzheimer’s disease, and inflammatory bowel diseases.
Partnering for research and development collaborations
Collaboration opportunities with academic and commercial partners to further develop programs in neurology, severe food allergies, seasonal allergies, and immunology.
Reviews

Aggregated rating

Aggregated rating
4
of 5

Aggregated from 5 reviews across all connected sources

Sources
GGoogle45
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

April 30, 2026Media
Three Swiss deep tech startups secure Eureka funding
startupticker.ch
April 30, 2026Media
Mabylon sichert sich Eurostar-Zuschuss von 1,46 Millionen Euro
punkt4.info
December 11, 2025Media
Mabylon beginnt Phase-I-Studie zur Prophylaxe bei Erdnussallergie
punkt4.info
August 12, 2025Media
Mabylon raises CHF 30 million to fight allergies with human-derived antibodies
startupticker.ch

Knowledge

No knowledge articles yet

Once Mabylon AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Mabylon AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Mabylon AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Mabylon AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 14
8952 Schlieren
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-353.226.343
Founded
2011 · 15 years
Last commercial register change
July 3, 2026
Employees
11 to 20

Similar companies

ST
Stiftung Technopark Zürich
Zurich
SO
SwissDrones Operating AG
Zurich
AH
A. Heim GmbH
Fehraltorf
SC
Stem Cell Bank of Switzerland GmbH
Zurich